• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.27% Nasdaq Up 0.84%

    Albany Molecular Research Inc. (AMRI)

    -NasdaqGS
    15.67 Up 0.48(3.16%) 3:45PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:15.19
    Open:15.32
    Bid:15.73 x 100
    Ask:15.74 x 300
    1y Target Est:20.50
    Beta:1.11
    Earnings Date:Feb 10 - Feb 16 (Est.)
    Day's Range:15.20 - 15.80
    52wk Range:9.94 - 23.95
    Volume:213,302
    Avg Vol (3m):523,548
    Market Cap:496.25M
    P/E (ttm):139.91
    EPS (ttm):0.11
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for AMRI

    Comparison

    Symbol% ChgMkt Cap
    AMRIUp 3.16%496.25M
    CVDUp 0.31%5.89B
    QUp 1.98%7.75B

    Key Statistics

    Forward P/E (1 yr):17.47
    P/S (ttm):1.87
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :0.68
    Quarterly EPS Est (Dec-14) :0.33
    Mean Recommendation*:2.3
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Albany Molecular Research, Inc., a contract research and manufacturing company, provides integrated drug discovery, development, and manufacturing services primarily in the United States, Europe, and Asia. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback